Rhelion Life Sciences Corp. (CSE:RHEL)
Canada · Delayed Price · Currency is CAD 0.0300
0.00 (0.00%)
Aug 10, 2026, 12:18 PM EST
Rhelion Life Sciences Cash Flow Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -6.1 | -4.04 | -7.63 | -5.4 | -14.37 |
Depreciation & Amortization | 0.36 | 0.78 | 0.93 | 0.63 | 0.52 |
Loss (Gain) From Sale of Assets | 0.03 | -0 | -0.01 | - | - |
Asset Writedown & Restructuring Costs | 2.15 | 0.53 | 2.03 | 0.44 | 5.94 |
Loss (Gain) From Sale of Investments | 0.68 | 0.24 | -0.12 | 0.35 | 0.22 |
Stock-Based Compensation | 0.58 | 0.58 | 1.41 | 0.59 | 3.25 |
Other Operating Activities | -0.6 | -0.81 | 0.03 | -0.33 | -0.27 |
Change in Accounts Receivable | -0.05 | 0.12 | -0.01 | -0.08 | -0.19 |
Change in Inventory | -0.15 | -0.13 | -0.13 | -0.17 | 0.1 |
Change in Accounts Payable | 0.56 | 0.27 | 0.39 | -0.15 | 0.23 |
Change in Income Taxes | -0.06 | 0.02 | 0.08 | -0.07 | -0.02 |
Change in Other Net Operating Assets | 0.18 | 0.96 | -0.21 | -0.21 | -0.3 |
Operating Cash Flow | -2.42 | -1.48 | -3.23 | -4.39 | -4.88 |
Operating Cash Flow Growth | - | - | - | - | - |
Capital Expenditures | -0.14 | -0.53 | -0.69 | -2.06 | -0.41 |
Sale of Property, Plant & Equipment | - | - | 0.03 | - | - |
Cash Acquisitions | - | - | - | -1.06 | -0.34 |
Investment in Securities | -1.09 | 0.01 | 0.01 | -0.05 | 0.16 |
Investing Cash Flow | -1.23 | -0.53 | -0.65 | -3.17 | -0.58 |
Short-Term Debt Issued | 0 | 0.22 | - | - | 0.29 |
Long-Term Debt Issued | - | 0.36 | - | - | - |
Total Debt Issued | 0 | 0.58 | - | - | 0.29 |
Long-Term Debt Repaid | -0.77 | -0.14 | -0.22 | -0.16 | -0.09 |
Total Debt Repaid | -0.77 | -0.14 | -0.22 | -0.16 | -0.09 |
Net Debt Issued (Repaid) | -0.77 | 0.45 | -0.22 | -0.16 | 0.2 |
Issuance of Common Stock | - | - | 0.1 | 0.05 | 0.25 |
Repurchase of Common Stock | - | - | -0.09 | - | - |
Financing Cash Flow | -0.77 | 0.45 | -0.21 | -0.11 | 0.45 |
Foreign Exchange Rate Adjustments | 0.05 | 0.03 | -0.03 | 0.07 | -0.08 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | -0 |
Net Cash Flow | -4.37 | -1.53 | -4.11 | -7.61 | -5.09 |
Free Cash Flow | -2.56 | -2.01 | -3.92 | -6.45 | -5.28 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -61.06% | -40.73% | -82.53% | -163.33% | -227.18% |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
Levered Free Cash Flow | -2.41 | -1.86 | -1.24 | -6.57 | -2.33 |
Unlevered Free Cash Flow | -2.38 | -1.68 | -1.08 | -6.53 | -2.3 |
Change in Working Capital | 0.49 | 1.25 | 0.12 | -0.68 | -0.17 |